Evidence for SARS-CoV-2 Delta and Omicron co-infections and recombination

BACKGROUND: Between November 2021 and February 2022, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Delta and Omicron variants co-circulated in the United States, allowing for co-infections and possible recombination events. METHODS: We sequenced 29,719 positive samples during this per...

Descripción completa

Detalles Bibliográficos
Autores principales: Bolze, Alexandre, Basler, Tracy, White, Simon, Dei Rossi, Andrew, Wyman, Dana, Dai, Hang, Roychoudhury, Pavitra, Greninger, Alexander L., Hayashibara, Kathleen, Beatty, Mark, Shah, Seema, Stous, Sarah, McCrone, John T., Kil, Eric, Cassens, Tyler, Tsan, Kevin, Nguyen, Jason, Ramirez, Jimmy, Carter, Scotty, Cirulli, Elizabeth T., Schiabor Barrett, Kelly, Washington, Nicole L., Belda-Ferre, Pedro, Jacobs, Sharoni, Sandoval, Efren, Becker, David, Lu, James T., Isaksson, Magnus, Lee, William, Luo, Shishi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2022
Materias:
Clinical and Translational Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9581791/
https://www.ncbi.nlm.nih.gov/pubmed/36332633
http://dx.doi.org/10.1016/j.medj.2022.10.002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9581791/
https://www.ncbi.nlm.nih.gov/pubmed/36332633
http://dx.doi.org/10.1016/j.medj.2022.10.002

Ejemplares similares